US 10583180
Method for treating adenosine deaminase severe combined imunodeficiency
granted A61KA61K35/28A61K38/50
Quick answer
US patent 10583180 (Method for treating adenosine deaminase severe combined imunodeficiency) held by The Regents of the University of California expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K35/28, A61K38/50, A61K48/0008, A61K48/0066